Delivery Order SPE2DB24D6038-SPE2DB25FELLL

Award Date 12/2/24
Potential Completion Date 12/3/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NovLog 100 unit/mL FlexPen 3mL insulin products. The contract has a ceiling value of $1,034.21 and a period of performance through June 28, 2024. It is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of NovLog 100 unit/mL FlexPen 3mL insulin syringes to the Department of Defense. The $3,927.97 contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical and medical supply distributor. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical,...
This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen® 3mL, a prescription insulin medication, to the Defense Logistics Agency (DLA). The $1,838.16 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 6, 2023. The contract has an ultimate completion date of April 7, 2023 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,356.48 Firm Fixed Price Delivery Order contract covers the supply of NovoPen 100 unit/mL FlexPen 3mL insulin pens. The award has a completion date of February 8, 2024 and was issued on February 7, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $1,048.70 firm-fixed-price delivery order is for the supply of NovoCare 100 unit/mL FlexPen 3mL insulin devices. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL FlexPen 3mL insulin products. The $1,810.80 fixed-price delivery order has a completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
This federal contract award is for the delivery of NovLog 100 Unit/ML Flexpen 3ML medication to the Defense Logistics Agency (DLA). The $1,633.92 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 28, 2023. The contract has an ultimate completion date of December 29, 2023 and is not set aside for any specific business type. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award is for the delivery of Novolin N 100 unit/mL Flexpen 3mL, a type of insulin medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The contract has a ceiling value of $1,036.40 and a completion date of September 20, 2023. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL Flexpen 3mL insulin pens. The contract has a ceiling value of $3,111.20 and a period of performance through May 31, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,815.98 firm fixed-price delivery order contract covers the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB24D6038
    Indefinite Delivery Contract
  • SPE2DB24D6038-SPE2DB25FELLL
    Delivery Order

This federal contract award is for the delivery of NovLog 100 unit/mL FlexPen 3mL insulin pens to the Defense Logistics Agency (DLA). The $1,056.60 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024, with a completion date of December 3, 2024. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare programs, Amerisourcebergen's extensive experience and capabilities in distributing essential medical commodities, including specialty medications, vaccines, and other pharmaceutical products, make it well-positioned to fulfill this contract for the DLA.

Generated 3/3/25, 12:28 PM